Do clinical guidelines facilitate or impede drivers of treatment in Fabry disease?

Do clinical guidelines facilitate or impede drivers of treatment in Fabry disease?

Abstract Background Variable disease progression confounds accurate prognosis in Fabry disease. Evidence supports the long-term benefit of early intervention with disease-specific therapy, but current guidelines recommend treatment initiation based on signs that may present too late to avoid irrever...

Full description

Bibliographic Details
Main Authors: Derralynn A. Hughes, Patrício Aguiar, Olivier Lidove, Kathleen Nicholls, Albina Nowak, Mark Thomas, Roser Torra, Bojan Vujkovac, Michael L. West, Sandro Feriozzi
Format: Article
Language:English
Published: BMC 2022-02-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Fabry disease
Guideline
Consensus
Renal
Cardiac
Neurological
Online Access:https://doi.org/10.1186/s13023-022-02181-4

Internet

https://doi.org/10.1186/s13023-022-02181-4

Similar Items